• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Neuropsychiatric Disorders Treatment Market

    ID: MRFR/HC/43512-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South Korea Neuropsychiatric Disorders Treatment Market Research Report By Type (Degenerative Diseases, Neurotic Disorders, Psychosis, Others), By Application (Shock Treatment, Drug Treatment, Others) and By End User (Hospitals, Clinics, Research Centre’s, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Neuropsychiatric Disorders Treatment Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    South Korea Neuropsychiatric Disorders Treatment Market Summary

    The South Korea Neuropsychiatric Disorders Treatment market is projected to grow significantly from 3.63 USD billion in 2024 to 10.1 USD billion by 2035.

    Key Market Trends & Highlights

    South Korea Neuropsychiatric Disorders Treatment Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 9.76 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 10.1 USD billion, indicating robust growth potential.
    • In 2024, the market is valued at 3.63 USD billion, reflecting the current demand for neuropsychiatric treatments.
    • Growing adoption of innovative treatment methodologies due to increasing awareness of mental health issues is a major market driver.

    Market Size & Forecast

    2024 Market Size 3.63 (USD Billion)
    2035 Market Size 10.1 (USD Billion)
    CAGR (2025-2035) 9.76%

    Major Players

    Soo)Gen Inc., Hanmi Pharmaceutical, Samsung Biologics, Medytox, Shin Poong Pharmaceutical, Genexine, Boryung Pharmaceutical, Yuhan Corporation, Hugel, Daewoong Pharmaceutical, LG Chem, Celltrion, DongA STSK Biopharmaceuticals, Korea United Pharm

    South Korea Neuropsychiatric Disorders Treatment Market Trends

    Various factors are shaping notable trends in the South Korea Neuropsychiatric Disorders Treatment Market. An increase in the awareness of mental health problems alongside ongoing changes in societal attitudes on help-seeking behavior towards neuropsychiatric disorders is mitigating market growth. The South Korean government has been executing mental health policies, offering special attention on premature intervention and focus in the area. Furthermore, there has been an increase in the number of specialized treatment centers and the availability of telemedicine, resulting in improved access to therapy.

    This coincides with the increase in the use of technology in healthcare, also referred to as digital health, which has gained traction in South Korea.

    As more personalized and novel treatment methods are sought after, these markets tend to have more opportunities available. There is a growing movement to develop drugs for treatment of neuropsychiatric disorders for depression, anxiety, schizophrenia, and other ailments and it is anticipated that many research institutions will start collaborating with drug companies to develop new therapies. In addition, there is already an established interest in wellness programs and other more holistic approaches that are integrative, like mindfulness and cognitive behavioral therapy, which compliment conventional treatments. This creates a chance to apply both clinical and non-clinical approaches to improve patients' health.

    Recent patterns have also indicated an increase in the integration of public and private funding for the treatment of neuropsychiatric disorders.

    As part of mental health strategies, there is an increased focus on enhancing the infrastructure of the mental health care system as well as the technology associated with it. In addition, due to the increase in the elderly population, there is a greater need for effective interventions for age-related neuropsychiatric disorders, which has spurred innovation in research and development. Therefore, the South Korea Neuropsychiatric Disorders Treatment Market is shifting in response to the demographic changes and showing their responsiveness in the provision of mental health services.

    Market Segment Insights

    South Korea Neuropsychiatric Disorders Treatment Market Segment Insights

    South Korea Neuropsychiatric Disorders Treatment Market Segment Insights

    Neuropsychiatric Disorders Treatment Market Type Insights

    Neuropsychiatric Disorders Treatment Market Type Insights

    The South Korea Neuropsychiatric Disorders Treatment Market presents a multifaceted landscape, primarily segmented by Type, which encompasses Degenerative Diseases, Neurotic Disorders, Psychosis, and Others. The rising prevalence of mental health issues in South Korea has significantly influenced the market dynamics, contributing to an overall increase in demand for effective treatment options and solutions. Among these segments, degenerative diseases, such as Alzheimer’s and Parkinson’s, hold substantial importance due to the aging population, which has led to an increased incidence of cognitive disorders. The country’s commitment to improving elderly care and mental health services showcases the growing acknowledgment of these challenges.

    In contrast, neurotic disorders, which include anxiety and depression, have emerged as a critical focus due to their high prevalence among younger demographics. The South Korean government has implemented various mental health initiatives and community programs aimed at decreasing the stigma associated with these disorders, further driving demand for effective therapeutic interventions. Psychosis, characterized by altered perceptions of reality, continues to represent a significant challenge to healthcare providers, necessitating advanced treatment strategies to address both pharmacological and psychotherapeutic needs. The increasing awareness of mental health alongside educational programs further emphasizes the significance of addressing this segment of the population.

    Moreover, the 'Others' category captures various fewer common disorders that still demand attention and treatment, ensuring that diverse needs within the population are met. Overall, the South Korea Neuropsychiatric Disorders Treatment Market segmentation reflects a growing recognition of the complexities involved in treating diverse mental health conditions, coupled with a commitment from governmental and healthcare entities to enhance the quality of care provided to patients. This focused approach is expected to foster innovation in treatment methodologies and contribute positively to the South Korea Neuropsychiatric Disorders Treatment Market revenue trajectory in the years ahead.

    Neuropsychiatric Disorders Treatment Market Application Insights

    Neuropsychiatric Disorders Treatment Market Application Insights

    The South Korea Neuropsychiatric Disorders Treatment Market is characterized by its diverse application spectrum, addressing various treatment modalities for neuropsychiatric conditions. Within this market, Shock Treatment and Drug Treatment are pivotal, with Shock Treatment being recognized for its efficacy in severe cases, often where traditional therapies have proven less effective. Drug Treatment, on the other hand, remains a critical option, with a broad range of pharmacological solutions targeting different disorders, significantly bolstered by ongoing research and development in the field.The others category encompasses alternative approaches and emerging therapies, highlighting the market's responsiveness to innovations and patient needs.

    As South Korea places a strong emphasis on mental health awareness and the integration of modern treatment methodologies, the overall dynamics of the South Korea Neuropsychiatric Disorders Treatment Market reflect the changing landscape of mental health care, aligning with growing public health initiatives and increasing government support for mental health programs. This changing environment offers substantial opportunities for growth, particularly as societal acceptance and recognition of these disorders continue to advance.

    Neuropsychiatric Disorders Treatment Market End User Insights

    Neuropsychiatric Disorders Treatment Market End User Insights

    The End User segment of the South Korea Neuropsychiatric Disorders Treatment Market is diverse and plays a crucial role in the effective management of mental health issues. Hospitals represent a critical component, providing acute and long-term care for individuals with severe neuropsychiatric conditions, ensuring comprehensive treatment in a well-equipped environment. Clinics, on the other hand, cater to outpatient services, allowing for ongoing management and therapy for patients seeking psychiatric care and support. Research centers contribute significantly by advancing the understanding of neuropsychiatric disorders through clinical studies and innovation, driving the development of more effective treatment modalities.

    Additionally, the "Others" category encompasses a variety of alternative care platforms, such as community services and online mental health platforms, reflecting a growing trend toward accessible and integrated care solutions. Collectively, these end users reflect a commitment to enhancing patient outcomes in South Korea, as the importance of mental health awareness rises in alignment with national health policies focusing on comprehensive psychiatric support.

    The South Korea Neuropsychiatric Disorders Treatment Market is likely to see substantial growth as demand for these services increases, fueled by growing awareness, changing societal attitudes towards mental health, and government initiatives aimed at improving mental healthcare access.

    Get more detailed insights about South Korea Neuropsychiatric Disorders Treatment Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    The South Korea Neuropsychiatric Disorders Treatment Market is characterized by a dynamic and competitive landscape where various pharmaceutical companies are relentlessly developing and commercializing innovative therapies to address a wide array of mental health disorders. With increasing awareness regarding mental health and the growing prevalence of conditions such as depression, anxiety, and schizophrenia, the market has garnered significant attention from both investors and healthcare providers. The competitive analysis within this sector reveals a focus on research and development, collaboration with healthcare institutions, and engaging in continuous clinical trials to enhance the efficacy and safety profiles of new psychiatric medications.

    Companies are striving to position themselves effectively amid stringent regulatory frameworks, diverse patient needs, and advancing technological solutions in treatment approaches, thus creating a robust competitive environment that fosters innovation.Soo)Gen Inc. holds a significant position in the South Korea Neuropsychiatric Disorders Treatment Market, renowned for its commitment to the research and development of groundbreaking therapies targeting neuropsychiatric conditions. The company has developed a portfolio of products that are aimed at addressing unmet medical needs within the psychiatric domain.

    Their strengths lie in their robust pipeline of drug candidates, which are undergoing various stages of clinical development, and their strategic collaborations with academic institutions and research organizations that enhance their innovation capabilities. Soo)Gen Inc. also emphasizes patient-centric approaches in its therapeutic strategies, focusing on improving patients' quality of life and therapeutic outcomes.

    By dedicated efforts in clinical research and engagement with the mental health community, Soo)Gen Inc. has established a credible presence in the neuropsychiatric treatment landscape of South Korea.Hanmi Pharmaceutical is another major player in the South Korean Neuropsychiatric Disorders Treatment Market, widely recognized for its comprehensive suite of products that address mental health challenges. The company has made significant strides in developing drugs that cater to various neuropsychiatric disorders, reflecting its strong commitment to mental health research. Hanmi Pharmaceutical possesses a solid market presence, bolstered by strategic mergers and acquisitions that have expanded their capabilities and resource access.

    Moreover, the company's strengths include its diverse portfolio of psychiatric medications that cater to a range of conditions, bolstered by significant investment in R&D to foster new product development. The firm has successfully formed partnerships with international stakeholders for collaborative studies and market expansions, further enhancing its competitive position within South Korea's mental health treatment domain. This proactive approach not only strengthens Hanmi Pharmaceutical's market presence but also enhances its reputation as a key contributor to innovations in neuropsychiatric treatment solutions.

    Key Companies in the South Korea Neuropsychiatric Disorders Treatment Market market include

    Industry Developments

    The South Korea Neuropsychiatric Disorders Treatment Market has been witnessing significant developments recently. Key players such as Hanmi Pharmaceutical and SK Biopharmaceuticals have made strides in advancing drug pipelines to address psychiatric conditions. The market is currently experiencing an uptick in investment, with companies like Samsung Biologics focusing on biologics for conditions like schizophrenia and depression. In terms of mergers and acquisitions, LG Chem announced a partnership with a biotech firm in August 2023 to expand its portfolio in neuropsychiatric treatments, enhancing its R&D capabilities.

    Additionally, Daewoong Pharmaceutical has been actively investing in innovative therapies, reflecting a broader trend of increased spending in the neuropsychiatric sector. The government's support for mental health initiatives further contributes to market growth, promoting accessibility and research funding. Over the past two years, there has been a noticeable increase in public awareness and reduced stigma regarding mental health, driving demand for products and services in this domain. As the market evolves, ongoing collaborations among key industry players are expected to create new opportunities for growth and innovation in South Korea's neuropsychiatric treatment landscape.

    Market Segmentation

    Outlook

    • Hospitals
    • Clinics
    • Research Centre’s
    • Others

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 3.29(USD Billion)
    MARKET SIZE 2024 3.63(USD Billion)
    MARKET SIZE 2035 10.11(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 9.773% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Soo)Gen Inc., Hanmi Pharmaceutical, Samsung Biologics, Medytox, Shin Poong Pharmaceutical, Genexine, Boryung Pharmaceutical, Yuhan Corporation, Hugel, Daewoong Pharmaceutical, LG Chem, Celltrion, DongA ST, SK Biopharmaceuticals, Korea United Pharm
    SEGMENTS COVERED Type, Application, End User
    KEY MARKET OPPORTUNITIES Aging population increasing treatment demand, Rising awareness of mental health, Advancements in telemedicine solutions, Growing investment in biotech research, Enhanced focus on personalized medicine
    KEY MARKET DYNAMICS Rising prevalence of mental disorders, Increasing awareness and acceptance, Advanced treatment technologies, Government healthcare initiatives, Growing investment in research
    COUNTRIES COVERED South Korea

    FAQs

    What is the expected market size of the South Korea Neuropsychiatric Disorders Treatment Market in 2024?

    The expected market size of the South Korea Neuropsychiatric Disorders Treatment Market in 2024 is valued at 3.63 billion USD.

    What will the market size be in 2035?

    In 2035, the market is projected to reach a value of 10.11 billion USD.

    What is the expected CAGR for the South Korea Neuropsychiatric Disorders Treatment Market from 2025 to 2035?

    The expected CAGR for the market from 2025 to 2035 is 9.773 percent.

    Which segment of the market is expected to have the largest value in 2035?

    The Degenerative Diseases segment is expected to have the largest value, reaching 2.92 billion USD in 2035.

    Who are the key players in the South Korea Neuropsychiatric Disorders Treatment Market?

    Key players include Soo)Gen Inc., Hanmi Pharmaceutical, Samsung Biologics, and many others.

    What is the market value for Neurotic Disorders in 2024?

    The market value for Neurotic Disorders in 2024 is estimated at 1.25 billion USD.

    What challenges might the South Korea Neuropsychiatric Disorders Treatment Market face in the coming years?

    Potential challenges include regulatory hurdles and market competition among major players.

    What trends are currently emerging in the South Korea Neuropsychiatric Disorders Treatment Market?

    Emerging trends include increased focus on personalized medicine and advancements in neuropharmaceuticals.

    What is the projected market value for the Psychosis segment in 2035?

    The Psychosis segment is projected to reach a market value of 2.42 billion USD in 2035.

    What are the anticipated growth drivers for the South Korea Neuropsychiatric Disorders Treatment Market?

    Growth drivers include rising awareness of mental health issues and advancements in treatment methodologies.

    South Korea Neuropsychiatric Disorders Treatment Market Research Report - Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials